CAPR
Capricor Therapeutics Inc.
$6.72
-$0.37(-5.22%)
41
Overall
--
Value
25
Tech
57
Quality
Market Cap
$304.02M
Volume
1.31M
52W Range
$5.68 - $23.40
Target Price
$20.60
EPS Estimates Overview
| Current Quarter | $-0.54 | Next Quarter | $-0.49 |
| Current Year | $-2.11 | Next Year | $0.03 |
| QoQ Growth | +9.3% | YoY Growth | +101.4% |
| 3Y EPS CAGR | -9.8% | Target Price | $20.60 |
| Consensus | Buy | Upside | +206.5% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CAPR | $6.72 | -5.2% | 1.31M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Capricor Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW